But on Thursday, Stephen Ubl, PhRMA’s president and chief executive, sat down for the first time this year with Rep. Richard Neal (D-Mass.), the chairman of the House Ways and Means Committee, which advanced the House drug-pricing proposal last month, according to a committee aide.
